[1] Speight PM, Takata T.New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours[J]. Virchows Arch, 2018, 472(3): 331-339. [2] Mendes RA, Carvalho JF, van der Waal I. Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features[J]. Oral Oncol, 2010, 46(4): 219-225. [3] Singh BN, Shankar S, Srivastava RK.Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications[J]. Biochem Pharmacol, 2011, 82(12): 1807-1821. [4] Khan N, Afaq F, Saleem M, et al.Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate[J]. Cancer Res, 2006, 66(5): 2500-2505. [5] Johnson NR, Batstone MD, Savage NW.Management and recurrence of keratocystic odontogenic tumor: a systematic review[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 116(4): e271-e276. [6] 胡永杰, 李思毅, 徐立群, 等. 减压术治疗下颌骨大型牙源性角化囊肿的临床研究[J]. 中国口腔颌面外科杂志, 2005, 3(4): 299-302. [7] Awni S, Conn B.Decompression of keratocystic odontogenic tumors leading to increased fibrosis, but without any change in epithelial proliferation[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017, 123(6): 634-644. [8] 胡秀莲, 王兴, 林野, 等. 人口腔黏膜角化上皮细胞的体外培养及生物学特性研究[J]. 中国口腔颌面外科杂志, 2004, 2(3): 173-176. [9] Guimaraes DM, Antunes DM, Saturno JL, et al.Immunohistochemical expression of WNT5A and MMPs in odontogenic epithelial tumors and cysts[J]. Acta Histochem, 2015, 117(8): 667-674. [10] Hakim SG, Kosmehl H, Sieg P, et al.Altered expression of cell-cell adhesion molecules beta-catenin/E-cadherin and related Wnt-signaling pathway in sporadic and syndromal keratocystic odontogenic tumors[J]. Clin Oral Investig, 2011, 15(3): 321-328. [11] 孔丽, 王炳超, 袁荣涛, 等. Wnt信号通路相关基因在颌骨牙源性角化囊性瘤中的表达及意义[J]. 上海口腔医学, 2015, 24(1): 89-93. [12] Chen PN, Chu SC, Kuo WH, et al.Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells[J]. J Agric Food Chem, 2011, 59(8): 3836-3844. [13] Xiang LP, Wang A, Ye JH, et al.Suppressive effects of tea catechins on breast cancer[J]. Nutrients, 2016, 8(8): E458. [14] Sakamoto Y, Terashita N, Muraguchi T, et al.Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis[J]. Biosci Biotechnol Biochem, 2013, 77(9): 1799-1803. [15] Yang C, Du W, Yang D.Inhibition of green tea polyphenol EGCG[(-)-epigallocatechin-3-gallate] on the proliferation of gastric cancer cells by suppressing canonical wnt/beta-catenin signalling pathway[J]. Int J Food Sci Nutr, 2016, 67(7): 818-827. [16] Min KJ, Kwon TK.Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate[J]. Integr Med Res, 2014, 3(1): 16-24. [17] Kikuchi A, Yamamoto H, Sato A.Selective activation mechanisms of Wnt signaling pathways[J]. Trends Cell Biol, 2009, 19(3): 119-129. [18] Katoh M.WNT/PCP signaling pathway and human cancer (review)[J]. Oncol Rep, 2005, 14(6): 1583-1588. [19] Görögh T, Bèress L, Quabius ES, et al.Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity[J]. Mol Cancer, 2013, 12: 12. [20] Long J, Cai L, Li J, et al.JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury[J]. Neural Regen Res, 2013, 8(16):1491-1499. [21] Pirianov G, Brywe KG, Mallard C, et al.Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury[J]. J Cereb Blood Flow Metab, 2007, 27(5): 1022-1032. |